Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001209191-23-024939

President and CEO acquired 279,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KIDRON NADAV President and CEO 2023-04-17 Grant or award +279,000 1,332,098 D
Loading xslF345X04/doc4.xml…